Related references
Note: Only part of the references are listed.Metformin as a host-directed therapeutic in tuberculosis: Is there a promise?
Wing Wai Yew et al.
TUBERCULOSIS (2019)
Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial
Chandrasekaran Padmapriyadarsini et al.
BMJ OPEN (2019)
Reduced prevalence of latent tuberculosis infection in diabetes patients using metformin and statins
Matthew J. Magee et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co-morbidity
Nathella P. Kumar et al.
IMMUNOLOGY (2019)
The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment
Sheng-Wei Pan et al.
CHEST (2018)
Diabetes is associated with increased prevalence of latent tuberculosis infection: Findings from the National Health and Nutrition Examination Survey, 2011-2012
Marissa M. Barron et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: experiences from 3-year follow-up
Y. Ma et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2018)
Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies
Simon Tiberi et al.
LANCET INFECTIOUS DISEASES (2018)
Metformin is associated with a lower risk of active tuberculosis in patients with type 2 diabetes
Shang-Yi Lin et al.
RESPIROLOGY (2018)
The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus
Ye-Jin Lee et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2018)
Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar
Mohammad H. Al-Shaer et al.
BMC INFECTIOUS DISEASES (2018)
Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatment
Nathella P. Kumar et al.
BMC INFECTIOUS DISEASES (2018)
Metformin use is associated with a low risk of tuberculosis among newly diagnosed diabetes mellitus patients with normal renal function: A nationwide cohort study with validated diagnostic criteria
Ming-Chia Lee et al.
PLOS ONE (2018)
Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients
Chin-Hsiao Tseng
JOURNAL OF CLINICAL MEDICINE (2018)
Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment
Nicholas R. Degner et al.
CLINICAL INFECTIOUS DISEASES (2018)
Influence of diabetes mellitus on immunity to human tuberculosis
Pavan Kumar Nathella et al.
IMMUNOLOGY (2017)
Statin Use Is Associated With a Lower Risk of TB
Vincent Yi-Fong Su et al.
CHEST (2017)
Protective effect of metformin against tuberculosis infections in diabetic patients: an observational study of south Indian tertiary healthcare facility
Srujitha Marupuru et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2017)
Increased risk of latent tuberculous infection among persons with pre-diabetes and diabetes mellitus
R. L. Hensel et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2016)
Glycemic Control and the Risk of Tuberculosis: A Cohort Study
Pin-Hui Lee et al.
PLOS MEDICINE (2016)
Diabetes Reduces the Rate of Sputum Culture Conversion in Patients With Newly Diagnosed Multidrug-Resistant Tuberculosis
Argita D. Salindri et al.
OPEN FORUM INFECTIOUS DISEASES (2016)
Diabetes mellitus and tuberculosis: programmatic management issues
A. D. Harries et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2015)
Metformin as a potential combination therapy with existing front-line antibiotics for Tuberculosis
Rohit Vashisht et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Advancing host-directed therapy for tuberculosis
Robert S. Wallis et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Latent Tuberculosis in Patients with Diabetes Mellitus: Prevalence, Progression and Public Health Implications
M. K. S. Leow et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2014)
Statin Therapy Reduces the Mycobacterium tuberculosis Burden in Human Macrophages and in Mice by Enhancing Autophagy and Phagosome Maturation
Suraj P. Parihar et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Metformin as adjunct antituberculosis therapy
Amit Singhal et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
A hands-on practical tutorial on performing meta-analysis with Stata
Anna Chaimani et al.
EVIDENCE-BASED MENTAL HEALTH (2014)
Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes
Maria Eugenia Jimenez-Corona et al.
THORAX (2013)
Risk Factors for Tuberculosis
Padmanesan Narasimhan et al.
PULMONARY MEDICINE (2013)
Metformin and the Risk of Cancer Time-related biases in observational studies
Samy Suissa et al.
DIABETES CARE (2012)
The impact of diabetes on tuberculosis treatment outcomes: A systematic review
Meghan A. Baker et al.
BMC MEDICINE (2011)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
Alessandro Liberati et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Tuberculosis and diabetes mellitus: convergence of two epidemics
Kelly E. Dooley et al.
LANCET INFECTIOUS DISEASES (2009)
Tuberculosis in poorly controlled type 2 diabetes: Altered cytokine expression in peripheral white blood cells
Blanca I. Restrepo et al.
CLINICAL INFECTIOUS DISEASES (2008)
Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 observational studies
Christie Y. Jeon et al.
PLOS MEDICINE (2008)
The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus
J. E. Stalenhoef et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2008)
Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis
Moises Palaci et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus (Withdrawn paper, art. no. CD002967, 2006)
S Salpeter et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2006)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Share Paper
